Inventor · disambiguated record
Kurt Gish
Also filed as: GISH KURT · GISH KURT C · GISH KURT CARLYLE
27 granted patents·30 pending applications·927 citations·filing 1997–2018
97Inventor score
Top patents by PatentIndex Score
57 records- 0196US6682890B2Methods of diagnosing and determining prognosis of colorectal cancerPROTEIN DESIGN LABS INC·Filed 2001·Granted Jan 27, 2004·108 cites·4 claims
- 0295US7189507B2Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancerPDL BIOPHARMA INC·Filed 2002·Granted Mar 13, 2007·65 cites·13 claims
- 0395US6020135AP53-regulated genesAFFYMETRIX INC·Filed 1998·Granted Feb 1, 2000·227 cites·24 claims
- 0492US6762020B1Methods of diagnosing breast cancerPROTEIN DESIGN LABS INC·Filed 2000·Granted Jul 13, 2004·51 cites·6 claims
- 0591US7435589B2Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancerPDL BIOPHARMA INC·Filed 2007·Granted Oct 14, 2008·15 cites·18 claims
- 0691US6750013B2Methods for detection and diagnosing of breast cancerPROTEIN DESIGN LABS INC·Filed 2000·Granted Jun 15, 2004·48 cites·8 claims
- 0790US6171798B1P53-regulated genesAFFYMETRIX INC·Filed 1999·Granted Jan 9, 2001·99 cites·33 claims
- 0888US8591863B2Compositions against cancer antigen LIV-1 and uses thereofLAW DEBBIE·Filed 2012·Granted Nov 26, 2013·7 cites·18 claims
- 0988US6723520B2Antibodies that bind chemokine teckSCHERING CORP·Filed 2002·Granted Apr 20, 2004·11 cites·22 claims
- 1087US10011657B2Anti-CS1 antibodies and antibody drug conjugatesABBVIE BIOTHERAPEUTICS INC·Filed 2015·Granted Jul 3, 2018·4 cites·16 claims
- 1187US8906342B2Compositions against cancer antigen LIV-1 and uses thereofLAW DEBBIE·Filed 2013·Granted Dec 9, 2014·4 cites·17 claims
- 1287US6420108B2Computer-aided display for comparative gene expressionAFFYMETRIX INC·Filed 1998·Granted Jul 16, 2002·129 cites·50 claims
- 1386US8313745B2Compositions against cancer antigen LIV-1 and uses thereofMACK DAVID·Filed 2010·Granted Nov 20, 2012·4 cites·6 claims
- 1485US10195209B2Anti-huLRRC15 antibody drug conjugates and methods for their useABBVIE INC·Filed 2016·Granted Feb 5, 2019·5 cites·32 claims
- 1585US7279460B2Chemokine TECK polypeptidesSCHERING CORP·Filed 2004·Granted Oct 9, 2007·7 cites·7 claims
- 1684US6780586B1Methods of diagnosing breast cancerPROTEIN DESIGN LABS INC·Filed 2000·Granted Aug 24, 2004·24 cites·8 claims
- 1780US6455668B1Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulatorsEOS BIOTECHNOLOGY INC·Filed 2000·Granted Sep 24, 2002·16 cites·16 claims
- 1878US11045480B2Anti-huLRRC15 antibody drug conjugates and methods for their useABBVIE INC·Filed 2018·Granted Jun 29, 2021·1 cites·6 claims
- 1977US10188660B2Anti-huLRRC15 antibody drug conjugates and methods for their useABBVIE INC·Filed 2016·Granted Jan 29, 2019·1 cites·27 claims
- 2077US7276238B2Methods for using chemokine teckSCHERING CORP·Filed 2004·Granted Oct 2, 2007·2 cites·20 claims
- 2177US6649342B1Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulatorsEOS BIOTECHNOLOGY INC·Filed 2000·Granted Nov 18, 2003·15 cites·16 claims
- 2275US6274312B1Intracellular regulatory molecules; related reagentsSCHERING CORP·Filed 1997·Granted Aug 14, 2001·32 cites·9 claims
- 2370US2009191629A1Mammalian chemokine reagentsSCHERING CORP·Filed 2009·Application pending·0 cites
- 2468US2010074841A1Compositions Against Cancer Antigen LIV-1 and Uses ThereofFACET BIOTECH CORP·Filed 2009·Application pending·0 cites
- 2568US2008175839A1Compositions Against Cancer Antigen LIV-1 and Uses ThereofPROTEIN DESIGN LABS INC·Filed 2007·Application pending·0 cites
- 2667US6566502B1Methods of diagnosing cancer, compositions, and methods of screening for cancer modulatorsEOS BIOTECHNOLOGY INC·Filed 2000·Granted May 20, 2003·7 cites·28 claims
- 2766US6294343B1Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulatorsEOS BIOTECHNOLOGY INC·Filed 1999·Granted Sep 25, 2001·27 cites·16 claims
- 2866US2008044835A1Mammalian chemokine reagentsWANG WEI·Filed 2007·Application pending·0 cites
- 2964US2008171039A1Compositions Against Cancer Antigen Liv-1 and Uses ThereofPROTEIN DESIGN LABS INC·Filed 2007·Application pending·0 cites
- 3062US10308713B2Anti-CS1 antibodies and antibody drug conjugatesABBVIE BIOTHERAPEUTICS INC·Filed 2017·Granted Jun 4, 2019·0 cites·20 claims
- 3162US2004141983A1Compositions against cancer antigen LIV-1 and uses thereofPROTEIN DESIGN LABS INC·Filed 2004·Application pending·0 cites
- 3260US2019099431A1ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USEABBVIE INC·Filed 2018·Application pending·0 cites
- 3352US2007059748A1Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancerPDL BIOPHARMA INC·Filed 2006·Application pending·0 cites
- 3451US2007059712A1Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancerGISH KURT C·Filed 2005·Application pending·0 cites
- 3550US2004029114A1Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancerEOS TECHNOLOGY INC·Filed 2002·Application pending·0 cites
- 3650US2013169645A1Computer-aided visualization of expression comparisonAFFYMETRIX INC·Filed 2012·Application pending·0 cites
- 3748US2004146862A1Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancerEOS BIOTECHNOLOGY INC·Filed 2001·Application pending·0 cites
- 3848US2003118509A1Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulatorsEOS BIOTECHNOLOGY INC·Filed 2002·Application pending·0 cites
- 3947US2007042360A1Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancerEOS BIOTECHNOLOGY INC·Filed 2002·Application pending·0 cites
- 4047US2004219579A1Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancerFiled 2004·Application pending·0 cites
- 4146US6773878B1Methods of diagnosing of colorectal cancer, compositions, and methods of screening for colorectal cancer modulatorsEOS BIOTECHNOLOGY INC·Filed 1999·Granted Aug 10, 2004·11 cites·12 claims
- 4246US2004241710A1Methods of detecting colorectal cancerFiled 2003·Application pending·0 cites
- 4346US2007014801A1Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancerGISH KURT C·Filed 2001·Application pending·0 cites
- 4445US2007067111A1Computer-aided visualization of expression comparisonAFFYMETRIX INC·Filed 2006·Application pending·0 cites
- 4544US2003108926A1Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulatorsEOS BIOTECHNOLOGY INC·Filed 2002·Application pending·0 cites
- 4644US2003124579A1Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancerEOS BIOTECHNOLOGY INC·Filed 2002·Application pending·0 cites
- 4744US2003157544A1Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulatorsEOS BIOTECHNOLOGY INC·Filed 2003·Application pending·0 cites
- 4843US2003087245A1Uses of PBH1 in the diagnosis and therapeutic treatment of prostate cancerEOS BIOTECHNOLOGY INC·Filed 2002·Application pending·0 cites
- 4942US2001039013A1P53-regulated genesFiled 2001·Application pending·0 cites
- 5042US2003232350A1Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancerEOS BIOTECHNOLOGY INC·Filed 2002·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kurt Gish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →